The adipogenic marker peroxisome proliferator-activated receptor alpha (PPARA) was found 1.25-fold upregulated in SAT, while fatty acid-binding protein 4 (FABP4) was decreased by 0.53-fold in VAT from MetS+ patients. This evidence concerns the gene FABP4 and metabolic syndrome.